Is low-dose cytarabine being overlooked in combination therapies for elderly AML?
The molecular mechanisms of epigenetic therapies: LTRs and TINATs
Perspectives in AML treatment: targeting apoptosis without chemotherapy by using BH3-mimetics
Targeted therapy of AML
Exciting improvements in amyloidosis management and treatment